CRAD001A2307
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRAD001A2307, covering 2011-11-02 to 2011-11-02. Get the full timeline:
Most recent: Clinical Trial Update: This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307. [Phase 3]